Circuit mechanisms of reward, anhedonia, and depression

A Höflich, P Michenthaler, S Kasper… - International Journal …, 2019 - academic.oup.com
Pleasure and motivation are important factors for goal-directed behavior and well-being in
both animals and humans. Intact hedonic capacity requires an undisturbed interplay …

A transdiagnostic review of negative symptom phenomenology and etiology

GP Strauss, AS Cohen - Schizophrenia bulletin, 2017 - academic.oup.com
In the DSM5, negative symptoms are 1 of the 5 core dimensions of psychopathology
evaluated for schizophrenia. However, negative symptoms are not pathognomonic—they …

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes

E Setiawan, AA Wilson, R Mizrahi, PM Rusjan… - JAMA …, 2015 - jamanetwork.com
Importance The neuroinflammatory hypothesis of major depressive disorder is supported by
several main findings. First, in humans and animals, activation of the immune system causes …

Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression

JC Felger, Z Li, E Haroon, BJ Woolwine, MY Jung… - Molecular …, 2016 - nature.com
Depression is associated with alterations in corticostriatal reward circuitry. One
pathophysiological pathway that may drive these changes is inflammation. Biomarkers of …

Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports

RC Kessler, HM van Loo, KJ Wardenaar… - Molecular …, 2016 - nature.com
Heterogeneity of major depressive disorder (MDD) illness course complicates clinical
decision-making. Although efforts to use symptom profiles or biomarkers to develop clinically …

Anhedonia and the brain reward circuitry in depression

M Heshmati, SJ Russo - Current behavioral neuroscience reports, 2015 - Springer
Anhedonia, or the loss of pleasure in previously rewarding stimuli, is a core symptom of
major depressive disorder that may reflect an underlying dysregulation in reward …

Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder

RC Kessler, HM van Loo, KJ Wardenaar… - Epidemiology and …, 2017 - cambridge.org
Backgrounds. Clinicians need guidance to address the heterogeneity of treatment
responses of patients with major depressive disorder (MDD). While prediction schemes …

Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder

RS McIntyre, H Loft, MC Christensen - … Disease and Treatment, 2021 - Taylor & Francis
Purpose Anhedonia is a core symptom of major depressive disorder (MDD), which has
important functional consequences for the patient. This post hoc analysis investigated the …

Inflammation and decreased functional connectivity in a widely-distributed network in depression: centralized effects in the ventral medial prefrontal cortex

L Yin, X Xu, G Chen, ND Mehta, E Haroon… - Brain, behavior, and …, 2019 - Elsevier
Major depressive disorder is a heterogeneous disease involving widespread disruptions in
functional brain networks, the neurobiological mechanisms of which are poorly understood …

Psychometric properties of the Positive and Negative Affect Schedule (PANAS) in a heterogeneous sample of substance users

K Serafini, B Malin-Mayor, C Nich… - The American journal …, 2016 - Taylor & Francis
ABSTRACT Background: The Positive and Negative Affect Schedule (PANAS) is a widely
used measure of affect. A comprehensive psychometric evaluation among substance users …